Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure supports the creation of bioactive molecules due to the presence of the trifluoromethyl group, which enhances metabolic stability and lipophilicity. Commonly employed in medicinal chemistry for constructing dihydroisoquinoline-based drug candidates, including those targeting neurological disorders and inflammation. Also utilized in research settings for building blocks in heterocyclic chemistry and in the design of enzyme inhibitors.